Clinical Trial Update: Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy [NA]

View source ↗

Summary

Clinical trial update exploring serum immunoglobulin G as a biomarker for diabetic nephropathy; no status or results provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: Assiut University | Conditions: Diabetic Nephropathies | NA | Status: UNKNOWN